Adamant Health accepted into NOME program

We are proud to announce that Adamant Health has been selected for the 2024 US MedTech program in the Nordic Mentor Network For Entrepreneurship (NOME).

NOME is an elite mentoring program that facilitates long-term mentorship by industry experts for promising life science projects and startups to help them reach their goals and technology milestones. The initial 18-month program is driven by the vision of transforming Nordic life science startups into internationally renowned commercial successes.

As part of the program, startups receive the unique opportunity to participate in the NOME Medtech Camp in Minneapolis, MN, giving exclusive access to the US eco-system and its stakeholders, including specific US advice via a team of US mentors, subject matter expertise, and potential US partners and investors.

Adamant Health's acceptance into the 2024 US MedTech program in NOME is a testament to our groundbreaking research and highly advanced technology, and we are looking forward to connecting with the world-class mentors that are selected from among the best life science experts in the Nordics and the US. Behind NOME are The Novo Nordisk Foundation, Medicon Village, KI Innovations AB, Turku Business Region, Oslo Cancer Cluster Incubator, Aleap, Vertical, BioInnovation Institute, Scanbalt, Life Science Nord and Accelerace, who have joined forces to ensure a unique combination of life science expertise and entrepreneurial knowledge.

Adamant Health is one of six companies selected for the 2024 US MedTech program in NOME.

Previous
Previous

Adamant Health selected for AMPlify – Accelerated US Market Entry program 2024

Next
Next

Towards an evolution in Parkinson’s disease treatment: Modern technology and biomarkers